byiShook Opinion
Jan 31, 2025 - 10:35
AbbVie stock surged early Friday after beating fourth-quarter expectations, largely on the back of its immunology drugs. The post AbbVie Jumps After Its Powerhouses, Skyrizi And Rinvoq, Continued To Dominate appeared first on Investor's Business Daily.
AbbVie stock surged early Friday after beating fourth-quarter expectations, largely on the back of its immunology drugs.
The post AbbVie Jumps After Its Powerhouses, Skyrizi And Rinvoq, Continued To Dominate appeared first on Investor's Business Daily.